[HTML][HTML] The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing …
Background Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7
million people worldwide. Significant limitations still exist in our understanding of CD. …
million people worldwide. Significant limitations still exist in our understanding of CD. …
[HTML][HTML] A scoping review of registry captured indicators for evaluating quality of critical care in ICU
Background Excess morbidity and mortality following critical illness is increasingly attributed
to potentially avoidable complications occurring as a result of complex ICU management (…
to potentially avoidable complications occurring as a result of complex ICU management (…
[HTML][HTML] Baseline results of a living systematic review for COVID-19 clinical trial registrations
BJ Maguire, ARD McLean, S Rashan… - Wellcome Open …, 2020 - ncbi.nlm.nih.gov
Background: Since the coronavirus disease 2019 (COVID-19) outbreak was first reported in
December 2019, many independent trials have been planned that aim to answer similar …
December 2019, many independent trials have been planned that aim to answer similar …
[HTML][HTML] Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
PJ Guérin, ARD McLean, S Rashan… - PLOS global public …, 2022 - journals.plos.org
Therapeutic efficacy in COVID-19 is dependent upon disease severity (treatment effect
heterogeneity). Unfortunately, definitions of severity vary widely. This compromises the meta-…
heterogeneity). Unfortunately, definitions of severity vary widely. This compromises the meta-…
[HTML][HTML] Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis
…, A Hawryszkiewycz, S Rashan… - PLoS Neglected …, 2021 - journals.plos.org
Background Despite a historical association with poor tolerability, a comprehensive review
on safety of antileishmanial chemotherapies is lacking. We carried out an update of a …
on safety of antileishmanial chemotherapies is lacking. We carried out an update of a …
[HTML][HTML] Protocol and statistical analysis plan for the mega randomised registry trial comparing conservative vs. liberal oxygenation targets in adults with nonhypoxic …
Background The effect of conservative vs. liberal oxygen therapy on 90-day in-hospital
mortality in adults who have nonhypoxic ischaemic encephalopathy acute brain injuries and …
mortality in adults who have nonhypoxic ischaemic encephalopathy acute brain injuries and …
[HTML][HTML] Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess …
Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis which can occur
after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL …
after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL …
[HTML][HTML] Infectious diseases data Observatory (IDDO) visceral Leishmaniasis library of clinical therapeutic studies: A protocol for a living systematic review of clinical …
S Singh-Phulgenda, S Rashan… - Wellcome Open …, 2022 - wellcomeopenresearch.org
Introduction: Visceral leishmaniasis (VL) is a vector-borne disease caused by protozoan
parasites of the genus Leishmania. The disease is endemic in parts of South Asia, East Africa, …
parasites of the genus Leishmania. The disease is endemic in parts of South Asia, East Africa, …
[HTML][HTML] Protocol for a systematic review of the evidence-based knowledge on the distribution, associated risk factors, the prevention and treatment modalities for …
BJ Maguire, P Shrestha, S Rashan… - Wellcome Open …, 2023 - wellcomeopenresearch.org
Introduction: Noma (cancrum oris) is a devastating opportunistic infection resulting in severe
tissue destruction that affects mouth and oro-facial structures. There are substantial gaps in …
tissue destruction that affects mouth and oro-facial structures. There are substantial gaps in …
[HTML][HTML] The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological …
ARD McLean, S Rashan, L Tran… - Wellcome Open …, 2022 - wellcomeopenresearch.org
Background: Many available medicines have been evaluated as potential repurposed
treatments for coronavirus disease 2019 (COVID-19). We summarise the registered study …
treatments for coronavirus disease 2019 (COVID-19). We summarise the registered study …